Takeda Pharmaceutical Company Limited
Close-out letter issued June 9, 2020 · Hikari, Japan
- Inspection
- Nov 18 – Nov 26, 2019
- Pages
- 6
- FEI number
- 3004664162
In short: On June 9, 2020, FDA sent Takeda Pharmaceutical Company Limited in Hikari, Yamaguchi (FEI 3004664162) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Takeda Pharmaceutical Company Limited inspected by FDA?
The inspection ran Nov 18 – Nov 26, 2019, and the Close-out letter is dated June 9, 2020.
How do I get the full Close-out letter for Takeda Pharmaceutical Company Limited?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.